| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President Crescendo Bioscience
1 company
Tobin Bernard serves as a President Crescendo Bioscience at MYGN. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $540K at current prices.
The biggest single holding is MYGN (~$540K) as President Crescendo Bioscience. The recent filings there lean toward selling, a net 11,712 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 1, 2019 | MYGN Myriad Genetics Inc | President Crescendo Bioscience | Sell | 11,712 | $40.00 | $468,480.00 | -7.4% |